참고문헌 (17)

1. Chem. Pharm. Bull. F. Araki 37 404 1989 10.1248/cpb.37.404 Araki, F., Nakamura, H., Nojima, N., Tsukumo, K. and Sakamoto, S., Stability of recombinant human epidermal growth factor in various solutions.Chem. Pharm. Bull., 37, 404-406 (1989). 

   상세보기

2. J. Exp. Med. G.I. Brown 163 1319 1986 10.1084/jem.163.5.1319 Brown, G.I., Curtsinger, L.J. and Brightwell, JR., Enhancement of epidermal regeneration by biosynthetic epidermal growth factor.J. Exp. Med., 163, 1319-1324 (1986). 

   상세보기

3. J. Cell. Sci. G. Carpenter 3 Suppl 1 1985 10.1242/jcs.1985.Supplement_3.1 Carpenter, G., Epidermal growth factor: biology and receptor metabolism.J. Cell. Sci., Suppl 3, 1-9 (1985). 

   상세보기

4. Ann. Rev. Biochem. G. Carpenter 48 193 1979 10.1146/annurev.bi.48.070179.001205 Carpenter, G. and Cohen, S., Epidermal growth factor.Ann. Rev. Biochem., 48, 193-216 (1979). 

   상세보기

5. J. Invest. Dermatol. M.W. Greaves 5 101 1980 Greaves, M.W., Lack of effect of topically applied epidermal growth factor (EGF) on epidermal growth in manin vivo., J. Invest. Dermatol., 5, 101-103 (1980). 

6. J. Clin. Endocrinol. Metab. H. Gregory 45 668 1977 10.1210/jcem-45-4-668 Gregory, H., Holmes, J.E. and Willshire, I.R., Urogastrone levels in the urine of normal adult humans.J. Clin. Endocrinol. Metab., 45 668-672 (1977). 

   상세보기

7. N. Engl. J. Med. T.K. Hunt 321 111 1989 10.1056/NEJM198907133210209 Hunt, T.K. and La Van F.B., Enhancement of wound healing by growth factors.N. Engl. J. Med., 321, 111-112 (1989). 

   상세보기

8. Yakuzaigaku Y. Kiyohara 54 117 1994 Kiyohara, Y., Komada, F., Iwakawa, S. and Katsuhiko, O., Improvement in wound healing by epidermal growth factor (EGF) ointment: efficacy of EGF ointment containing protease inhibitor, nafamostat, for ischemic ulcer (decubitus) in rats.Yakuzaigaku, 54, 117-121 (1994). 

   상세보기

9. Pharm. Res. S. Kobayashi 11 1239 1994 10.1023/A:1018926007902 Kobayashi, S., Kondo, S. and Juni, K., Study on pulmonary delivery of salmon calcitonin in rats; Effects of protese inhibitors and absorption enhancers,Pharm. Res., 11, 1239-1243 (1994). 

   상세보기

10. J. Clin. Invest. S.E. Lynch 84 640 1989 10.1172/JCI114210 Lynch, S.E., Colvin, R.B. and Antoniades, H.N., Growth factors in wound healing.J. Clin. Invest., 84, 640-646 (1989). 

    상세보기

11. Int. J. Pharm. T. Murakami 46 9 1988 10.1016/0378-5173(88)90003-8 Murakami, T., Kawakita, H., Kishimoto, M., Higashi, Y., Amagase, H., Hayashi, T., Nojima, N., Fuwa, T. and Yata, N., Intravenous and subcutaneous pharmacokinetics and rectal bioavailability of human epidermal growth factor in the presence of absorption promoter in rats.Int. J. Pharm., 46, 9-17 (1988). 

    상세보기

12. Clin. Res. L.B. Nanney 35 706a 1987 Nanney, L.B., Epidermal growth factor-induced effects on wound healing.Clin. Res., 35, 706a (1987). 

13. Pharm. Res. K. Okumura 7 1289 1990 10.1023/A:1015946123697 Okumura, K., Kiyohara, Y., Komada, F., Iwakawa, S., Hirai, M. and Fuwa, T., Improvement in wound healing by epidermal growth factor (EGF) ointment. I. Effect of nafamostat, gabexate, or gelatin on stabilization and efficacy of EGF.Pharm. Res., 7, 1289-1293 (1990). 

    상세보기

14. J. Cell. Biochem. G. Schultz 45 346 1991 10.1002/jcb.240450407 Schultz, G., Rotatori, D.S. and Clark, W., EGF and TGF-α in wound healing and repair.J. Cell. Biochem., 45, 346-352 (1991). 

    상세보기

15. J. Invest. Dermatol. Y. Suga 101 346 1993 10.1111/1523-1747.ep12365519 Suga, Y., Takamori, K. and Ogawa, H., Skin proteasomes (high molecular weight protease): Purification, enzymologic properties, gross structure and their tissue distribution,J. Invest. Dermatol., 101, 346-351 (1993). 

    상세보기

16. Arch. Dermatol. Res. Y. Suzuki 285 372 1993 10.1007/BF00371839 Suzuki, Y., Nomura, J., Hori, J., Koyama, J., Takahashi, M. and Hori, I., Detection and characterization of endogenous protease associated with desquamation of stratum corneum.,Arch. Dermatol. Res., 285, 372-377 (1993). 

    상세보기

17. Pharm. Res. M. Takeyama 8 60 1991 10.1023/A:1015878222769 Takeyama, M., Ishida, T., Kokubu, N., Komada, F., Iwalawa, S., Okumura, K. and Hori, R., Enhanced bioavailability of subcutaneously injected insulin by pretreatment with ointment containing protease inhibitors.,Pharm. Res., 8, 60-64 (1991). 

    상세보기